|
|
|
|
|
HONG KONG, July 16, 2015 - (ACN Newswire) - Uni-Bio Science Group Limited ("Uni-Bio" or the "Group";HKEx code: 690) has garnered the "Pharmaceuticals Award" for Best Innovation with its Uni-E4 project at the inaugural Hong Kong Business ("HKB") Listed Companies Awards. As the winner under the pharmaceuticals category, the accolade is a strong testimony for the innovation of Uni-Bio's Uni-E4, the Group's proprietary recombinant GLP-1 receptor agonist for the treatment of Type-2 diabetes.
 | | Uni-Bio Science Group Garners "Pharmaceuticals Award" for Best Innovation at Hong Kong Business Listed Companies Awards |
Mr. Kingsley Leung, Executive Director of Uni-Bio Science Group, said, "Competing alongside industry peers, we are delighted to be chosen as the winner in the pharmaceuticals category at the HKB Listed Companies Awards. This accolade acknowledges 10 years of hard work by our highly-skilled R&D team in developing Uni-E4. Compared to existing products, Uni-E4 offers a cost-effective alternative to manage diabetes and associated complications - it can effectively reduce blood sugar levels without the increased risk of hypoglycemia, and provide other collateral benefits, such as weight loss and stimulating beta cell regeneration. Therefore, Uni-E4 offers patients, especially overweight diabetics, with a long-term solution for managing their illness. These innovations were instrumental in Uni-Bio garnering this prestigious award. In the future, we will continue fulfilling our commitment to identify and develop new and more efficacious treatment options for our targeted patients in order to better treat their illnesses."
Contact:
Strategic Financial Relations Limited
Veron Ng Phone: +852 2864 4831 Email: veron.ng@sprg.com.hk
Angelus Lau Phone: +852 2864 4805 Email: angelus.lau@sprg.com.hk
Caley Chan Phone: +852 2114 4950 Email: caley.chan@sprg.com.hk
Fax: +852 2527 1196
Topic: Press release summary
Source: Uni-Bio Science Group Limited
Sectors: Daily Finance
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
